Use of a Near Infrared Probe to Assess Intracellular Hydrogen Sulfide Production

利用近红外探针评估细胞内硫化氢的产生

阅读:1

Abstract

INTRODUCTION: Hydrogen sulfide (H(2)S) is a ubiquitous gas that has recently garnered significant interest as a potential therapeutic agent for various ischemic and inflammatory diseases. Therefore, effective H(2)S detection methods may be beneficial for translational research applications for these diseases. In the current study, a near-infrared H(2)S (NIR-HS) probe was synthesized and hypothesized that the probe would allow for qualitative assessment of H(2)S in biological systems. MATERIALS AND METHODS: The NIR-HS probe was synthesized and purified using chromatography. The ability of the NIR-HS probe to detect H(2)S was first determined in cell-free environments when H(2)S salts sodium sulfide (Na(2)S), sodium hydrosulfide (NaHS) and a H(2)S-slow-releasing donor (p-methoxyphenyl)morpholino-phosphinodithioic acid (GYY4137), were used. Three mammalian cell lines (HIEC6, HEK293T, and vertebral bone adherent mesenchymal stem cell) were treated with NaHS (H(2)S donor) or ZnCl(2) (negative control) in the presence of the NIR-HS probe. NIR-HS probe was also tested in cells that either overexpressed H2S synthases (CBS, CTH, and mercaptopyruvate sulfurtransferase) or had reduced levels of H2S synthases. The fluorescent responses of NIR-HS were determined by fluorescent microscopy and flow cytometry. RESULTS: In a cell-free system, the NIR-HS probe showed a statistically significant increase in fluorescence with the addition of Na(2)S, NaHS, or GYY4134 compared to vehicle alone, and dose-dependent responses to H(2)S donors. In mammalian cells, H(2)S donors increased and ZnCl(2) decreased the fluorescent responses of NIR-HS. Knocking down and overexpressing the endogenous H(2)S synthases altered the production of H(2)S, respectively. CONCLUSIONS: This NIR-HS probe was shown to be a useful compound in the detection of H(2)S in cell-free and cellular environments. Further studies are needed to demonstrate its use within in vivo applications of specific ischemic and inflammatory disease models prior to clinical translation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。